Untargeted DNA-Demethylation Therapy Neither Prevents Nor Attenuates Ischemia-Reperfusion-Induced Renal Fibrosis

Benjamin A. Vervaet, Lies Moonen, Lode Godderis, Katrien Poels, Patrick C. D’Haese

˜The œNephron journals/Nephron journals · 2017 · 12 citations · 28 references

Abstract

Administration of untargeted nucleoside analogues seems unsuitable as a first-line treatment option in developing or established CKD.

References

28